Abstract
Parathyromatosis is a rare condition consisting of multiple nodules of benign hyperfunctioning parathyroid tissue scattered throughout the neck and superior mediastinum. As a potential cause of recurrent or persistent hyperparathyroidism, parathyromatosis is a challenging condition to diagnose and treat. The optimal evaluation and management of patients with parathyromatosis is not well established. The reported case involves a patient who was initially diagnosed with primary hyperparathyroidism. The diagnosis of Type 1 parathyromatosis was made after the patient developed recurrent hyperparathyroidism with hypercalcemia and osteoporosis 17 years after the initial operation and underwent two additional operations. The majority of parathyromatosis cases are diagnosed in the setting of secondary hyperparathyroidism. Consensus regarding the preoperative diagnosis and evaluation is lacking due to the paucity of cases of this rare clinical entity. Management involves complete surgical extirpation of all identifiable rests of parathyroid tissue. Intra-operative parathyroid hormone level monitoring and frozen section examination are excellent tools that could increase the rates of initial operative success. Despite this, long-term disease remission is rare, and medical therapy, including calcimimetics and bisphosphonates, may be required for postoperative or non-operative management.
Similar content being viewed by others
References
J.A. Palmer, W.A. Brown, W.H. Kerr, I.B. Rosen, N.A. Watters, The surgical aspects of hyperparathyroidism. Arch. Surg. 110, 1004–1007 (1975)
Z.W. Baloch, V.A. LiVolsi, Pathology of the parathyroid glands in hyperparathyroidism. Semin. Diagn. Pathol. 30(3), 165–177 (2013). doi:10.1053/j.semdp.2013.06.003
R. Fitko, S.I. Roth, J.R. Hines, D.M. Roxe, E. Cahill, Parathyromatosis in hyperparathyroidism. Hum. Pathol. 21, 234–237 (1990)
E.J. Lentsch, K.P. Withrow, D. Ackermann, J.M. Bumpous, Parathyromatosis and recurrent hyperparathyroidism. Arch. Otolaryngol. Head Neck Surg. 129, 894–896 (2003)
S. Matsuoka, Y. Tominaga, T. Sato, N. Uno, N. Goto, A. Katayama, K. Uchida, T. Tsuzuki, Recurrent renal hyperparathyroidism caused by parathyromatosis. World J. Surg. 31(2), 299–305 (2007). doi:10.1007/s00268-006-0391-z
C. Stehman-Breen, N. Muirhead, D. Thorning, D. Sherrard, Secondary hyperparathyroidism complicated by parathyromatosis. Am. J. Kidney Dis. 28(4), 502–507 (1996)
A.L. Melck, S.E. Carty, R.R. Seethala, M.J. Armstrong, M.T. Stang, J.B. Ogilvie, L. Yip, Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy. Surgery 148(4), 867–873 (2010). doi:10.1016/j.surg.2010.07.037. discussion 873–865
L. Falvo, A. Catania, S. Sorrenti, V. D’Andrea, M. Santulli, E. De Antoni, Relapsing secondary hyperparathyroidism due to multiple nodular formations after total parathyroidectomy with autograft. Am. Surg. 69(11), 998–1002 (2003)
E. Daphnis, K. Stylianou, I. Katsipi, S. Stratigis, E. Karamitopoulou, N. Karkavitsas, J. Kyriazis, Parathyromatosis and the challenge of treatment. Am. J. Kidney Dis. 48(3), 502–505 (2006). doi:10.1053/j.ajkd.2006.05.010
M.E. Tublin, J.H. Yim, S.E. Carty, Recurrent hyperparathyroidism secondary to parathyromatosis. J. Ultrasound Med. 26, 847–851 (2007)
I.W. Sim, S. Farrell, S. Grodski, C. Jung, K.W. Ng, Parathyromatosis following spontaneous rupture of a parathyroid adenoma: Natural history and the challenge of management. Intern. Med. J. 43(7), 819–822 (2013). doi:10.1111/imj.12185
C. Kollmorgen, M. Aust, J. Ferreiro, J. McCarthy, J.A. Van Heerden, Parathyromatosis: A rare yet important cause of persistent or recurrent hyperparathyroidism. Surgery 116(1), 111–115 (1994)
D. Xu, Y. Yin, L. Hou, W. Dai, Surgical management of secondary hyperparathyroidism: How to effectively reduce recurrence at the time of primary surgery. J. Endocrinol. Invest. 39(5), 509–514 (2016). doi:10.1007/s40618-015-0410-8
United States Renal Data System: 2015 Annual Data Report. In: NIDDK (ed.). Bethesda, MD, (2015).
R.L. Reddick, J.C. Costa, S.J. Marx, Parathyroid hyperplasia and parathyromatosis. Lancet 1, 549 (1977)
G.G. Fernandez-Ranvier, E. Khanafshar, K. Jensen, R. Zarnegar, J. Lee, E. Kebebew, Q.Y. Duh, O.H. Clark, Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110(2), 255–264 (2007). doi:10.1002/cncr.22790
M.P. Hage, I. Salti, G. El-Hajj Fuleihan, Parathyromatosis: A rare yet problematic etiology of recurrent and persistent hyperparathyroidism. Metabolism 61(6), 762–775 (2012). doi:10.1016/j.metabol.2011.11.001
Z.W. Baloch, D. Fraker, V.A. LiVolsi, Parathyromatosis as cause of recurrent secondary hyperparathyroidism: A cytologic diagnosis. Diagn. Cytopathol. 25(6), 403–405 (2001)
M.L. Kendrick, J.W. Charboneau, K.J. Curlee, J.A. Van Heerden, D.R. Farley, Risk of parathyromatosis after fine-needle aspiration. Am. Surg. 67(3), 290–294 (2001)
P. Lee, R. Mateo, M. Clarke, M. Brown, S. Carty, Parathyromatosis: A cause for recurrent hyperparathyroidism. Endocr. Pract. 3, 189–192 (2001)
A. Scorza, A. Moore, M. Terry, L. Bricker, Secondary parathyromatosis in a patient with normal kidney function: Review of diagnostic modalities and approaches to management. Endocr. Pract. 20(1), e4–e7 (2014)
K. Edling, S. Korenman, C. Janzen, M. Sohsman, S. Apple, S. Bhuta, M. Yeh, A pregnant dilemma: Primary hyperparathyroidism due to parathyromatosis in pregnancy. Endocr. Pract. 20(2), e14–e17 (2014)
T.J. Wu, Y.T. Wang, H. Chang, S.H. Lin, Parathyromatosis. Kidney Int. 82(10), 1140 (2012). doi:10.1038/ki.2012.257
R.Y. Osamura, J.L. Hunt, Current practices in performing frozen sections for thyroid and parathyroid pathology. Virchows Arch. 453(5), 433–440 (2008). doi:10.1007/s00428-008-0674-x
W.T. Shen, Parathyromatosis and parathyroid cancer. Cancer Treat. Res. 153, 105–116 (2010). doi:10.1007/978-1-4419-0857-5_7
N. Pinnamaneni, P.R. Shankar, A. Muthukrishnan, 99mTc MIBI SPECT findings in parathyromatosis—A rare entity causing recurrent hyperparathyroidism. Clin. Nucl. Med. 38, e443–e445 (2013)
A. Mohammadi, M. Ghasemi-Rad, Parathyromatosis or recurrent multiple parathyroid adenomas? A case report. Maedica 7(1), 66–69 (2012)
S. Cham, A.R. Sepahdari, K.E. Hall, M.W. Yeh, A. Harari, Dynamic parathyroid computed tomography (4DCT) facilitates reoperative parathyroidectomy and enables cure of missed hyperplasia. Ann. Surg. Oncol. 22(11), 3537–3542 (2015). doi:10.1245/s10434-014-4331-0
M.M. Mortenson, D.B. Evans, J.E. Lee, G.J. Hunter, D. Shellingerhout, T. Vu, B.S. Edeiken, L. Feng, N.D. Perrier, Parathyroid exploration in the reoperative neck: Improved preoperative localization with 4D-computed tomography. J. Am. Coll. Surg. 206(5), 888–895 (2008). doi:10.1016/j.jamcollsurg.2007.12.044. discussion 895–886
C. Vulpio, G. D’Errico, M.V. Mattoli, M. Bossola, C. Lodoli, G. Fadda, I. Bruno, A. Giordano, M. Castagneto, Recurrent renal hyperparathyroidism due to parathyromatosis. NDT Plus 4(5), 318–320 (2011). doi:10.1093/ndtplus/sfr075
A. D’Avanzo, S. Parangi, E. Morita, Q.-Y. Duh, A.E. Siperstein, Hyperparathyroidism after thyroid surgery and autotransplantation of histologically normal parathyroid glands. J. Am. Coll. Surg. 190(5), 546–552 (2000)
A. Aksoy-Altinboga, A. Akder Sari, T. Rezanko, M. Haciyanli, A. Orgen Calli, Parathyromatosis: Critical diagnosis regarding surgery and pathologic evaluation. Korean J. Pathol. 46(2), 197–200 (2012). doi:10.4132/KoreanJPathol.2012.46.2.197
W. Shen, M. Duren, E. Morita, C. Higgins, Q.-Y. Duh, A.E. Siperstein, O.H. Clark, Reoperation for persistent or recurrent primary hyperparathyroidism. Arch. Surg. 131(8), 861–869 (1996)
A.C. Powell, H.R. Alexander, R. Chang, S.J. Marx, M. Skarulis, J.F. Pingpank, D.L. Bartlett, M. Hughes, L.S. Weinstein, W.F. Simonds, M.F. Collins, T. Shawker, C.C. Chen, J. Reynolds, C. Cochran, S.M. Steinberg, S.K. Libutti, Reoperation for parathyroid adenoma: A contemporary experience. Surgery 146(6), 1144–1155 (2009)
N. Uno, Y. Tominaga, S. Matsuoka, T. Tsuzuki, S. Shimabukuro, T. Sato, N. Goto, T. Nagasaka, A. Katayama, K. Uchida, Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J. Surg. 32(11), 2516–2519 (2008). doi:10.1007/s00268-008-9739-x
K. Welch, C.R. McHenry, The role of transcervical thymectomy in patients with hyperparathyroidism. Am. J. Surg. 203(3), 292–295 (2012). doi:10.1016/j.amjsurg.2011.09.013. discussion 295–296
J.A. Palmer, I.B. Rosen, Reoperative surgery for hyperparathyroidism. Am. J. Surg. 144, 406–410 (1982)
B. Twigt, T. van Dalen, T. Vroonhoven, E. Consten, Recurrent hyperparathyroidism caused by benign neoplastic seeding: Two cases of parathyromatosis and a review of the literature. Acta Chir. Belg. 113(3), 228–232 (2013)
G.L. Irvin III, D.L. Prudhomme, G.T. Deriso, G. Sfakianakis, S.K.C. Chandarlapaty, A new approach to parathyroidectomy. Ann. Surg. 219(5), 574–581 (1994)
S. Matsuoka, Y. Tominaga, T. Sato, N. Uno, N. Goto, A. Katayama, K. Uchida, H. Takami, QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism. World J. Surg. 31(4), 824–831 (2007). doi:10.1007/s00268-006-0601-8
P.P. Parikh, J.C. Farra, B.J. Allan, J.I. Lew, Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism. Am. J. Surg. 210(1), 117–122 (2015). doi:10.1016/j.amjsurg.2014.09.039
G. Gasparri, M. Camandona, U. Bertoldo, A. Sargiotto, M. Papotti, E. Raggio, L. Nati, P. Martino, G. Felletti, G. Mengozzi, The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism. Ann. Surg. 250(6), 868–871 (2009). doi:10.1097/SLA.0b013e3181b0c7f4
B.S. Miller, B.G. England, M. Nehs, R.E. Burney, G.M. Doherty, P.G. Gauger, Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL. Surgery 140(6), 883–889 (2006). doi:10.1016/j.surg.2006.07.016. discussion 889–890
G.C. Karakousis, D. Han, R.R. Kelz, D. Nemani, J. Karamacharya, R. Roses, P.A. Gimotty, D.L. Fraker, Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT). Surgery 142(6), 845–850 (2007). doi:10.1016/j.surg.2007.09.009. discussion 850 e841–e842
S.C. Pitt, R. Panneerselvan, R.S. Sippel, H. Chen, Radioguided parathyroidectomy for hyperparathyroidism in the reoperative neck. Surgery 146(4), 592–598 (2009). doi:10.1016/j.surg.2009.06.031. discussion 598–599
G. Crouzeix, V. Kerlan, Primary hyperparathyroidism: New concepts, new recommendations. Ann. Endocrinol. (Paris) 75(Suppl 1), S21–S36 (2014)
J. Montenegro, I. Cornago, I. Gallardo, P. Garcia-Ledesma, A. Hernando, I. Martinez, R. Munoz, M. Romero, Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis. Nephrology (Carlton) 17(1), 26–31 (2012)
V. Marotta, C. Di Somma, M. Rubino, C. Sciammarella, M. Del Prete, F. Marciello, V. Ramundo, L. Circelli, P. Buonomano, R. Modica, M. Vitale, A. Colao, A. Faggiano, Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. Endocrine 49(1), 274–278 (2015). doi:10.1007/s12020-014-0381-0
A.A. Khan, J.P. Bilezikian, A.W. Kung, M.M. Ahmed, S.J. Dubois, A.Y. Ho, D. Schussheim, M.R. Rubin, A.M. Shaikh, S.J. Silverberg, T.I. Standish, Z. Syed, Z.A. Syed, Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89(7), 3319–3325 (2004). doi:10.1210/jc.2003-030908
C. Marcocci, J. Bollerslev, A.A. Khan, D.M. Shoback, Medical management of primary hyperparathyroidism: Proceedings of the fourth international workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(10), 3607–3618 (2014). doi:10.1210/jc.2014-1417
J.-V. Torregrosa, A. Moreno, M. Mas, J. Ybarra, D. Fuster, Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis. Kidney Int. 63(85), S88–S90 (2003)
Funding
This study was funded by The Margie and Robert E. Petersen Foundation and The Fashion Footwear Charitable Foundation of New York, Inc.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Informed consent was obtained from the patient discussed in the case report. No studies or procedures were performed solely for research purposes. This article does not contain any studies with animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Jain, M., Krasne, D.L., Singer, F.R. et al. Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis. Endocrine 55, 643–650 (2017). https://doi.org/10.1007/s12020-016-1139-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1139-7